--- title: Six ways to gain an advantage in market access planning and execution description: Adapting to the recent changes in market access requirements can truly give you a competitive advantage. Discover six ways to gain the advantage now. image: https://www.tribecaknowledge.com/hs-fs/hub/329676/file-1564191642.jpg --- # Six ways to gain an advantage in market access planning and execution - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-author.png) Andre Moa - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-date.png) 11 Aug 2014 - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-length.png) 4 minute read - [**](https://twitter.com/intent/tweet?text=https%3A%2F%2Fwww.tribecaknowledge.com%2Fblog%2Fsix-ways-to-gain-an-advantage-in-market-access-planning-and-execution%2F) - [**](https://www.linkedin.com/sharing/share-offsite/?url=https://www.tribecaknowledge.com/blog/six-ways-to-gain-an-advantage-in-market-access-planning-and-execution/) ![market_access-3.jpg](https://www.tribecaknowledge.com/hs-fs/hub/329676/file-1564191642.jpg?width=378&height=241&name=file-1564191642.jpg)   We are witnessing an increasingly challenging payer environment, with elements of value-based pricing being introduced in many markets. This means that optimising your market access effort and aligning activities across markets is more important than ever. At the same time, the rise of the emerging markets (where the real growth potential is) means that global market access teams are looking after a wider range of markets.   So how do you ensure your company has the competitive edge to bring your medicine to market quickly, efficiently and with fewer restrictions?     With a specialised market access tool, tailored to your specific processes and challenges, you can achieve a quicker, more efficient and successful route to market. Ensure your market access tool tackles these six challenges before you begin your road to market:   # **1)     Facilitate market access planning**   [A key challenge of modern market access is delivering the necessary information to the relevant customers and stakeholders at the right time](http://www.haygroup.com/downloads/ww/life-sciences-market-access-exec-summary-sreen.pdf). The wrong information at the wrong time could see one or more competitors gaining reimbursement before you, which in some markets could effectively shut you out of the market.   A tool tailored to your specific market access processes, will facilitate planning and help co-ordinate, align and sequence market access activities across countries and functional areas. The tool should make it clear who is doing what and when, and guide team members to focus on the most critical issues at any given time to make sure milestones are met.   # **2)     Track status and timelines efficiently**   Your teams will want to keep on schedule, but the fluid nature of timeline documents can make version control difficult, [particularly when using generic tools like Excel](https://www.tribecaknowledge.com/blog/index.php/6-reasons-market-access-launch-efforts-will-suffer-excel-sharepoint/). It can be even harder for global teams to track the status of all the different activities across country and functional teams. Without visibility of this, a co-ordinated launch will be hard to achieve.   By deploying specialist pharma market access tools instead, you can empower your teams to track the status of market access activities, highlighting areas where they are at risk of falling behind.  As a result, you will have the visibility you require to make informed decisions.   # **3)     Improve decision making**   The path to market is rarely a straight and simple road.  Global teams will need to decide which way to steer the market access process on a global level or within specific countries/regions.   By providing dashboards and data visualisation for all market access activities, you enable teams to make better informed decisions. Teams can use these dashboards to gain full visibility of status and timelines for all activities and milestones across global and affiliate teams, as well as pricing and reimbursement details, helping to make strategic decisions that will determine your market access success.   # **4)     Share insights**   Tailoring submissions to meet the very specific requirements of each reimbursement system and expectations of each individual payer is another key challenge for modern pharma market access.   The best way to confront this challenge is to share payer information and insights between your teams, helping them learn from each other in the same way payers are increasingly sharing data (including your pricing) across regions. As you develop a deep understanding of a particular payer environment, is it important that these insights are shared with other launch teams that will be dealing with the payer in due course.   Capturing and sharing these insights should be an integral part of the tool you are using to manage your market access planning and execution.   # **5)     Manage corporate intelligence**   Just think of how much experience your team has from being on the firing line and getting your products to market. Everything from an innovative way of demonstrating value to a payer, to your in-depth understanding of a particular reimbursement system to insights about a key payer – all of this information is extremely useful. But how much of this intelligence would be retained if you lost one of your key team members tomorrow?   By creating a database for this corporate intelligence, you ensure that when people move on, the corporate intelligence doesn't move with them. What’s more, this information can seamlessly evolve with the addition of new team members, creating a vast wealth of useful intelligence. Again, this is another key challenge your market access tool must address.   # **6)     Maximise your global knowledge**   We’ve mentioned the subtle differences between payers in different countries, and it’s true you should be tailoring your submission to address their specific requirements.   Your market access tool should also facilitate the dissemination of value propositions, value dossiers and evidence effectively across markets in a format that is easy to localise. By fixing this sixth and final pillar of a successful market access in place, you can maximise the utilisation of global knowledge, allowing local country teams to tailor them for each market in order to strengthen their submissions.   The bottom line? If you want to remain competitive and stand out from the crowd, it’s vital that you streamline your market access planning and execution to make sure it’s clear who is doing what, when, and to ensure market access teams have access to the right data from the right markets at the right time.   This challenge can be met with a market access toolkit specifically designed for this new era of pharma launches and tailored to your needs. For more information on developing an efficient strategy for your teams, [download our free market access checklist now](https://info.tribecaknowledge.com/pharma-launch-readiness-checklist-guide) for expert tips to optimise your market access toolkit. * *   [See all posts](https://www.tribecaknowledge.com/blog) - [**](https://twitter.com/intent/tweet?text=https%3A%2F%2Fwww.tribecaknowledge.com%2Fblog%2Fsix-ways-to-gain-an-advantage-in-market-access-planning-and-execution%2F) - [**](https://www.linkedin.com/sharing/share-offsite/?url=https://www.tribecaknowledge.com/blog/six-ways-to-gain-an-advantage-in-market-access-planning-and-execution/) TRiBECA® Knowledge provides cloud-based tools loved by the world’s leading pharmaceutical companies. Our SaaS platforms help manage launch readiness, market access, tenders and capability - while promoting collaboration, efficiency, and ease of use. Our flagship [SmartLaunch®](https://www.tribecaknowledge.com/smartlaunch-launch-readiness-software-for-pharmaceutical-and-biotech) product brings the entire launch team together to drive collaboration, transparency and efficiency across the launch programme. [SmartAccess™](https://www.tribecaknowledge.com/smartaccess-market-access-software-for-pharmaceutical-and-biotech) gives you a complete view of reimbursement status, timelines and data across countries and your product portfolio. Alongside [SmartPipeline™](https://www.tribecaknowledge.com/pipeline-management-software-for-pharmaceutical-and-biotech), [SmartTender™](https://www.tribecaknowledge.com/smarttender-tender-management-software-for-pharmaceutical-and-biotech), [SmartSkills™](https://www.tribecaknowledge.com/smartskills-capability-management-software-for-pharmaceutical-and-biotech) and SmartKnowledge™, our software solutions give you the tools you need to effectively commercialize your pharma products while building a robust organisational knowledge base. ### Recent Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) - [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) ### Most Popular Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) ### Categories - [launch readiness](https://www.tribecaknowledge.com/blog/topic/launch-readiness) - [Market access](https://www.tribecaknowledge.com/blog/topic/market-access) - [Pharma trends](https://www.tribecaknowledge.com/blog/topic/pharma-trends) - [Pharma launch planning](https://www.tribecaknowledge.com/blog/topic/pharma-launch-planning) - [launch plan](https://www.tribecaknowledge.com/blog/topic/launch-plan) - [launch readiness framework](https://www.tribecaknowledge.com/blog/topic/launch-readiness-framework) - [launch effectiveness](https://www.tribecaknowledge.com/blog/topic/launch-effectiveness) - [launch strategy](https://www.tribecaknowledge.com/blog/topic/launch-strategy) - [Tender Management](https://www.tribecaknowledge.com/blog/topic/tender-management) ## Related blogs ### [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) FDA and EMA approvals are down in 2025 as major US and EU reforms shift pricing and access. Explore the trends shaping drug launches and market entry. [Read more](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) ### [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) Driving launch excellence through agile transformation — how biopharma teams can reduce uncertainty, enhance learning, and accelerate successful launches. [Read more](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) ### [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) Pharma innovation stays strong, but market access barriers persist. Discover key trends and strategies in our Launch Readiness 2025 report. [Read more](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) #### Get our latest posts in your inbox TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.